Trump cracks down on drug pricing! ADMS earnings report positive.

Trump announces plans to reduce drug prices for Americans. I explain why I don’t think it will. 2018-Q1 earnings report from ADAMAS.     *None of this is financial advice. This is only opinion and not meant to be taken as suggestions for your own financial activities.*

Reformulating Old Drugs for Commercial Success – Adamas Pharmaceuticals

The San Diego based drug company, Adamas Pharmaceuticals, popped last week after Kerrisdale Capital Management announced they were long. I spent some time digging around to see if the claims Kerrisdale made were realistic and actually give ADMS a value of $100/share. Gocovri for Dyskinesia in Parkinson Disease Parkinson Disease (PD) affects about 7-10 million […]